The U.S. Food and Drug Administration (FDA) issued an approval letter for the Planmed Clarity 2-D full-field digital mammography (FFDM) system on Dec. 28, 2017, the company announced. The Planmed Clarity 2-D system is a digital mammography system that provides high image quality, optimal ergonomics and excellent usability for breast cancer screenings, according to the company. In addition to screening mammograms, the system supports diagnostic work-up examinations and biopsy procedures.